Beam Therapeutics Inc. Logo

Beam Therapeutics Inc. (BEAM)

BMV

Currency in MXN
439.00
0.00 (0.00%)

Real-time Data

02:30 PM

Day's Range

439.00
439.00

52 wk Range

398.00
655.00

Profile - BEAM - Beam Therapeutics Inc.

Profile

Mic Code

XMEX

Sector

Healthcare

Industry

Biotechnology

Employees

540


Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines using its proprietary base editing platform. The company works on therapies designed to make targeted, single-letter changes in DNA without creating double-strand breaks, supporting programs aimed at serious genetic and hematologic diseases. Its current pipeline includes research and clinical candidates across areas such as blood disorders, liver diseases, and other rare conditions. Beam Therapeutics also maintains integrated capabilities in gene editing, delivery, and internal manufacturing to support the development of its therapeutic candidates. Based in Cambridge, Massachusetts, Beam Therapeutics plays a role in the advanced genomics and gene-editing market, where precision medicine approaches are being applied to address diseases with limited treatment options.

Profile Details

Type

Common Stock

Address

238 Main Street

City

Cambridge

State

MA

Zip

02142

Country

United States

Phone

857 327 8775

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.